Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis

TY - JOUR

T1 - Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis

AU - Warford, Jordan R.

AU - Lamport, Anna Claire

AU - Clements, Derek R.

AU - Malone, Alicia

AU - Kennedy, Barry E.

AU - Kim, Youra

AU - Gujar, Shashi A.

AU - Hoskin, David W.

AU - Easton, Alexander S.

N1 - Funding Information: This study was funded by the Canadian Institutes of Health Research (operating grant to SG), Natural Sciences and Engineering Research Council (discovery grant to DH) and Dalhousie Medical Research Foundation (research grant to AE).

PY - 2018/1/4

Y1 - 2018/1/4

KW - Experimental autoimmune encephalomyelitis

KW - Lysolecithin

KW - Multiple sclerosis

KW - Proteoglycan

KW - Surfen

UR - http://www.scopus.com/inward/record.url?scp=85053352808&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053352808&partnerID=8YFLogxK

U2 - 10.1186/s40478-017-0506-9

DO - 10.1186/s40478-017-0506-9

M3 - Article

C2 - 29301568

AN - SCOPUS:85053352808

SN - 2051-5960

VL - 6

SP - 4

JO - Acta neuropathologica communications

JF - Acta neuropathologica communications

IS - 1

ER -